Physician profile
Debon Crews
NPI 1073864385
$1,114.07
in general payments reported to CMS, 2019-2025
9 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $225 · 2021: $104 · 2022: $157 · 2023: $153 · 2024: $32.99 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389 · Entertainment: $59.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.37 |
| Entertainment | $59.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $431.92 | 2020-2025 | Precision7, Total30 |
| Coopervision INC. | $166.11 | 2020-2023 | Myday Contact Lens |
| Optos, INC. | $143.69 | 2020-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Ivantis, INC | $125.00 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $119.27 | 2025 | Acuvue |
| Glaukos Corporation | $59.60 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.36 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debon Crews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.